Who owns MAIA BIOTECHNOLOGY INC?
- Ticker: MAIA
- CUSIP Number: 552641102
Tip: Access positions for across all investors
Analyze quarterly positions in Maia Biotechnology with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Maia Biotechnology stock
Who bought or sold MAIA BIOTECHNOLOGY INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Vanguard Group | 282k | $620k | 62% | Mar 2024 |
|
| Centric Wealth Management | 67k | $197k | 0% | Mar 2024 |
|
| Geode Capital Management | 53k | $117k | 20% | Mar 2024 |
|
| Bridgeway Capital Management | 46k | $101k | -11% | Mar 2024 |
|
| Jane Street | 25k | $55k | 100% | Mar 2024 |
|
| Citadel Advisors | 24k | $52k | -59% | Mar 2024 |
|
| Naviter Wealth | 22k | $49k | 0% | Mar 2024 |
|
| Northern Trust | 20k | $45k | 100% | Mar 2024 |
|
| BlackRock | 17k | $37k | 22% | Mar 2024 |
|
| Wealth Enhancement Advisory Services | 16k | $35k | 8% | Mar 2024 |
|
| Morgan Stanley | 10k | $22k | 98% | Mar 2024 |
|
| Tower Research Capital | 5.7k | $13k | 15% | Mar 2024 |
|
| Sunbelt Securities | 100.00 | $220.000000 | -33% | Mar 2024 |
|
| Wells Fargo & Company | 91.00 | $199.999800 | 32% | Mar 2024 |
|
| Jpmorgan Chase & Co | 38.00 | $83.999000 | -51% | Mar 2024 |
|
| Royal Bank of Canada | 28.00 | $0 | -81% | Mar 2024 |
|
| Mather Group | 24.00 | $28.000800 | 100% | Mar 2024 |
|
Who sold out of Maia Biotechnology?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Brookstone Capital Management | Dec 2023 | 13k | $15k |
| UBS Group | Dec 2023 | 998.00 | $1.2k |